0000905718-21-000630.txt : 20210429 0000905718-21-000630.hdr.sgml : 20210429 20210429160602 ACCESSION NUMBER: 0000905718-21-000630 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210429 FILED AS OF DATE: 20210429 DATE AS OF CHANGE: 20210429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Praill Anthony Scott CENTRAL INDEX KEY: 0001332948 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37823 FILM NUMBER: 21870486 MAIL ADDRESS: STREET 1: 2001-889 HOMER STREET CITY: VANCOUVER STATE: A1 ZIP: V6B 5S3 FORMER NAME: FORMER CONFORMED NAME: Praill Scott DATE OF NAME CHANGE: 20050713 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kintara Therapeutics, Inc. CENTRAL INDEX KEY: 0001498382 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 990360497 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 12707 HIGH BLUFF DR., SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 350-4364 MAIL ADDRESS: STREET 1: 12707 HIGH BLUFF DR., SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: DelMar Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20130123 FORMER COMPANY: FORMER CONFORMED NAME: Berry Only Inc. DATE OF NAME CHANGE: 20100805 4 1 kintara_fm4apr292021.xml X0306 4 2021-04-29 0 0001498382 Kintara Therapeutics, Inc. KTRA 0001332948 Praill Anthony Scott 12707 HIGH BLUFF DR. SUITE 200 SAN DIEGO CA 92130 0 1 0 0 Chief Financial Officer Common Stock 2021-04-29 4 J 0 8 0 A 7548 D Common Stock 2021-04-29 4 C 0 938 A 8486 D Series B Convertible Preferred Stock 2021-04-29 4 C 0 3750 0 D 2016-04-29 Common Stock 938 0 D The shares were issued as dividends to April 29, 2021 on the reporting person's shares of Series B Preferred Stock. Each share of Series B Preferred Stock was mandatorily converted on April 29, 2021 pursuant to the terms of the Series B Preferred Stock set forth in the Certificate of Designations of Series B Preferred Stock. Each share of Series B Preferred Stock was convertible into 0.25 shares of common stock equating to a conversion price of $32.00. /s/ Anthony Scott Praill 2021-04-29